Open AccessFatal interstitial lung disease associated with AZD9291
Author(s) -
Shengming Deng,
Jian-An Huang,
Yanbin Chen
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.199380
Subject(s) - interstitial lung disease , medicine , lung cancer , epidermal growth factor receptor , tyrosine kinase , cancer research , lung , mutation , disease , cancer , pathology , receptor , biology , genetics , gene
AZD9291 is one of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) for non-small cell lung cancer (NSCLC). Interstitial lung disease (ILD) induced by AZD9291 is very seldom. We provide a case of NSCLC treated with AZD9291 who developed ILD and died in order to improve the knowledge on AZD9291.